Page 148 - medicina-integrativa_compress

CAPÍTULO 13 ENFERMEDAD DE ALZHEIMER 141

BIBLIOGRAFÍA 23. Weindruch R, Walford RL: The retardation of aging and disease
by dietary restriction. Springfield, IL, Charles C Thomas, 1998.
1. Ernst R, Hay J: The U.S. economic and social cost of Alzheimer’s 24. Verdery R, Walford R: Caloric restriction in biosphere II: Effects of
disease revisited. Am J Public Health 84:1261-1264, 1991. energy restriction on lipid and lipoprotein levels and HDL
2. Thal LJ: Trials to prevent Alzheimer’s disease in a population at risk. subfractions [abstract no. 75, p 37]. Paper presented at the Annual
Abstract presented at the Fourth International Nice/Springfield Meeting of the American Aging Association, 1996, Los Angeles.
Symposium on Advances in Alzheimer Therapy [p 86], 1996, Nice, 25. Zhang X, Zhand BZ, Zhang WW: Protective effects of nicotinic acid
France. on disturbance of memory induced by cerebral ischemia-reperfusion
3. Lupien S: Personal communication, 1999. in rats. Clin J Pharm Toxicol 10:178-180, 1996.
4. Snowdon DA, Kemper SJ, Mortimer JA, et al: Linguistic ability in 26. Peetot GJ, Cole R, Conaway C, et al: Adult lifetime dietary patterns
early life and cognitive function and Alzheimer’s disease in late life: of antioxidant vitamin and carotenoid consumption in a case
Findings from the nun study. JAMA 275:528-532, 1996. control study of risk factors for Alzheimer’s disease [abstract no. 78,
5. Reimen EM, Caselli RJ, Yun L, et al: Preclinical evidence of p 38]. Paper presented at the Annual Meeting of the American
Alzheimer’s disease in persons homozygous for the e 4 allele for Aging Association, 1996, Los Angeles.
apolipoprotein E. N Engl J Med 334:752-758, 1996. 27. Sano M, Ernesto C, Thomas RG, et al: A controlled trial of
6. Gatz M, Lowe B, Berg S, et al: Dementia: Not just a search for the selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s
gene. Gerontologist 34:251-255, 1994. disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med
7. Birge SJ, Mortel KF: Estrogen and the treatment of Alzheimer’s 336:1216-1222, 1997.
disease. Am J Med 103:36S-45S, 1997. 28. Crook TN, Petrie W, Wells C, Massari DC, et al: Effects of
8. Katzman R, Kawas C: The epidemiology of dementia and phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull
Alzheimer’s disease. In Jerry RD, Katzman R, Bich KL (eds): 28:61-66, 1992.
Alzheimer Disease. New York, Raven Press, 1994, pp 105-122. 29. Gindin J, Nouikov D, Kedar A, et al: The effect of plant
9. Shah Y, Tangalos E, Petersen R: Mild cognitive impairment: When is phosphatidylserine on age-associated memory impairment and
it a precursor to Alzheimer’s disease? Geriatrics 55:62-68, 2000. mood in the functional elderly. Unpublished paper from The
10. Grant WB: Dietary links to Alzheimer’s disease. Alzheimer Dis Rev Geriatric Institute for Education and Research, and Department
2:42-45, 1997. of Geriatrics, Kaplan Hospital, Rehovot, Israel, 1995.
11. Hendrie HC, Ogunniyi A, Hall KS, et al: Incidence of dementia and 30. Beal FM: Cell death by oxidants: Neuroprotective antioxidant
Alzheimer disease in two communities. JAMA 285:739-747, 2001. therapies. Abstract presented at the Fourth International
12. Lupien S, Lecour SA, Lussier I, et al: Basal cerebral cortisol levels and Nice/Springfield Symposium on Advances in Alzheimer Therapy,
cognitive deficits in human aging. J Neurosci 14:2893-2903, 1994. 1996, Nice, France.
13. Stein-Behrens BA, Sapolsky RM: Stress, glucocorticoids, and aging. 31. LeBars PL, Katz MM, et al: A placebo-controlled, double-blind,
Aging (Milano) 4:197-210, 1992. randomized trial of an extract of Ginkgo biloba for dementia.
14. Sapolsky RM, McEwen BS: Stress, glucocorticoids, and their role in JAMA 278:1327-1332, 1997.
degenerative changes in the aging hippocampus. In Crook T, Bartus 32. Jevening R, Wilson AF, Davidson JM: Adrenocortical activity during
R (eds): Treatment Development Strategies for Alzheimer’s Disease. meditation. Horm Behav 10:54-60, 1978.
Madison, CT, MPA Press, 1986. 33. Wallace RR: The Physiology of Consciousness. Joint Publication
15. McEwen BS, Sapolsky RM: Stress and cognitive functions. Curr of the Institute of Science, Technology, and Public Policy, Portland,
Opin Neurobiol 5:205-206, 1995. OR, and Maharishi International University Press, Fairfield, IA.
16. Khalsa DS, Stauth C: Meditation as Medicine: Activate the 34. Alexander CN, Langer EJ, Newman RI: Transcendental meditation:
Power of Your Natural Healing Force. New York, Pocket Books, Mindfulness and longevity in experimental studies in the elderly.
2001. J Pers Soc Psychol 6:950-964, 1989.
17. Gould LK, Ornish D, Scherwitz L, et al: Changes in myocardial 35. Khalsa DS, Stauth C: Meditation As Medicine. New York, Pocket
perfusion abnormalities by positron emission tomography after Books, 2001.
long-term, intense risk factor modification. JAMA 274:894-901, 36. Khalsa DS: Exelon: A new drug for Alzheimer’s disease. Int J
1995. Anti-Aging Med 1:10-12, 1998.
18. Smith AL, Fredlund R: The protective effects of physical exercise 37. Riekhman, Pasio: Rationale to treat AD with selegiline. Presented at
on the development of Alzheimer’s disease [abstract]. Neurology the Fourth International Nice/Springfield Symposium on Advances
50:A89-A90, 1998. in Alzheimer Therapy, April 1996, Nice, France.
19. Diamond MC, Lindner B, Johnson R, Bennett EL: Differences 38. Rhodes ME, Li PK, Flood JF, Johnson DA: Enhancement of
in occipital corticol synapses from environmentally enriched, hippocampal acetylcholine release by the neurosteroid
impoverished, and standard colony rats. J Neurosci Res dehydroepiandrosterone sulfate: An in vivo microdialysis study.
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
1:109-119, 1975. Brain Res 733:284-286, 1996.
20. Cotman C: Synaptic plasticity, neurotrophic factors, and 39. Flood JF, Morley JE, Roberts E: Memory-enhancing effects in male
transplantation in the aged brain. In Schneider E, Rowe J (eds): mice of pregnenolone and steroids metabolically derived from it.
Handbook of the Biology of Aging, 3rd ed. New York, Academic Proc Natl Acad Sci U S A 89:1567-1571, 1992.
Press 1990, pp 255-274. 40. Berge SJ, Mortel KF: Estrogen and the treatment of Alzheimer’s
21. Walford RL, Spindler SR: The response to caloric restriction in disease. Am J Med 103:36S-45S, 1997.
mammals shows features also common to hibernation: A cross- 41. Larson DB: Scientific research on spirituality and health: The
adaptation hypothesis. J Gerontol 52:179-183, 1997. consensus report. Washington, DC, National Institute for
22. Weindruch R: Caloric restriction and aging. Sci Am 274:46-52, 1996. Healthcare Research, 1997.